Healthcare >> CEO Interviews >> November 1, 1999
DAVID B. MCWILLIAMS has served as President and Chief Executive Officer
and as a member of the Board of Directors of Texas Biotechnology Corp.
since July 1992. Prior to joining Texas Biotechnology he served as
President, Chief Executive Officer of Zonagen, Inc., a pharmaceutical
research company involved in reproductive health, from June 1989 to July
1992, where he was also a Director. He was President and Chief Executive
Officer of Kallestad Diagnostics, a medical diagnostics manufacturing
company, from 1984-1988. Mr. McWilliams served as President of E.M.
Industries, Harleco Diagnostics Division, from 1980-1984. He has held
various executive and senior management positions with Abbott
Laboratories, McKinsey & Company and Amoco Chemicals Corporation, and
currently serves as a Director of Structural Bioinformatics, Inc. Mr.
McWilliams received a BS from Washington and Jefferson College in
Chemistry, graduating magna cum laude and Phi Beta Kappa, and received
an MBA from the University of Chicago. Profile
Biotechnology Corporation, the company's history, activities, those
kinds of things.
Mr. McWilliams: The company is
